Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations

doi:10.3748/wjg.v17.i1.123

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3749)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

413

HTML

2950

Figures (1-1)

204

Tables (1-4)

182

Sum=3749

Jan 7, 2011 (publication date) through Sep 18, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 7, 2011; 17(1): 123-129
Published online Jan 7, 2011. doi: 10.3748/wjg.v17.i1.123

Table 2 Locations of lesions in patients undergoing percataneous and surgical radiofrequency ablation

	RFA
	Percataneous (n = 89)	Surgical (n = 108)
Segment location
I	0	0
II	7	12
III	13	17
IV	9	12
V	10	14
VI	6	11
VII	12	20
VIII	12	7
Adjacent vessels or organs
PH	8	12
RHV	17	15
MHV	8	12
LHV	11	16
IVC	6	8
Heart	3	5
Stomach	9	17
Lung	15	2
R.Kidney	4	7
Colon	5	12
GB	3	2

P = 0.640 by Pearson χ² test for segment location and P = 0.054 by Pearson χ² test for adjacent vessels or organs. Lesion between segments was registered at the major location. n: Lesion number; RFA: Radiofrequency ablation; PH: Porta hepatis; RHV: Right hepatic vein; MHV: Middle hepatic vein; LHV: Left hepatic vein; IVC: Inferior vena cava; GB: Gall bladder.

Citation: Huang JW, Hernandez-Alejandro R, Croome KP, Yan LN, Wu H, Chen ZY, Prasoon P, Zeng Y. Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations. World J Gastroenterol 2011; 17(1): 123-129
URL: https://www.wjgnet.com/1007-9327/full/v17/i1/123.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i1.123